Adjuvo's investment in Modern Baker has supported a £2.5 million Series A funding round, backing the food-tech company’s mission to transform ultra-processed foods into healthier everyday staples. This investment will help Modern Baker scale its platform, bringing healthier versions of everyday staples to consumers while keeping taste, convenience, and manufacturing efficiency intact.

Modern Baker has developed a unique ingredient-led technology platform and fully licensable IP. This innovation enables food manufacturers to produce healthier staples without compromising the qualities that consumers love. By tackling ultra-processed foods (UPFs), Modern Baker demonstrates that UPFs can be part of the solution to improving population health, not just the problem. Furthermore, the platform’s flexibility allows for rapid adaptation across multiple food categories, creating significant opportunities for both manufacturers and consumers.

SUPERLOAF: On the Shelves

The company’s proof-of-concept product, SUPERLOAF, is now available in major retailers including Marks & Spencer, Sainsbury’s, and Ocado Retail. SUPERLOAF delivers measurable benefits for blood glucose management and gut health.

Moreover, these real-world results validate the wider potential of Modern Baker’s platform, showing that healthier staples can achieve scale and impact. The product has also been positively received by consumers, reinforcing the market demand for nutritious yet convenient foods.

Scaling Through Licensing Partnerships

With Hovis Ltd signed as the first licensee, Modern Baker is demonstrating how its platform integrates seamlessly with existing manufacturing infrastructure. This approach enables global scalability without requiring new production lines, reducing cost and complexity for manufacturers.

In addition, licensing provides a fast route to market, allowing Modern Baker to focus on innovation while partners handle large-scale production and distribution.

Backing Innovation in Food-Tech

Adjuvo is proud to support Leo Campbell and the Modern Baker team as they build a radically different food-tech business. The investment reflects our commitment to backing companies that combine technology, science, and commercial ambition to tackle big societal challenges, such as population health.

“Modern Baker has created a platform that can transform how the world consumes everyday foods. By combining science, technology, and taste, they show that ultra-processed foods can improve health outcomes at scale. We are excited to back Leo and the team as they scale SUPERLOAF and expand the impact of their licensable technology.”

The Future of Healthy Ultra-Processed Foods

Looking ahead, Modern Baker aims to extend its platform beyond bread to other core food categories. This vision aligns with a broader trend in food-tech: applying innovation to deliver both health benefits and commercial viability.

Moveover, the company’s approach demonstrates that food-tech can drive measurable population-level health improvements while remaining attractive to consumers and profitable for manufacturers.

You can read more about this investment in the full article published by The Grocer here.